These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3777037)

  • 1. Variability in potassium removal by hemodialysis.
    Sherman RA; Hwang ER; Bernholc AS; Eisinger RP
    Am J Nephrol; 1986; 6(4):284-8. PubMed ID: 3777037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-charged dialysate for children on hemodialysis: acute dialytic changes.
    Fischbach M; Terzic J; Bitoun Cohen C; Cousandier E; Hamel G; Battouche D; Geisert J
    Pediatr Nephrol; 1998 Jan; 12(1):60-2. PubMed ID: 9502570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a new model of hemodialysis potassium removal on the control of ventricular arrhythmias.
    Redaelli B; Locatelli F; Limido D; Andrulli S; Signorini MG; Sforzini S; Bonoldi L; Vincenti A; Cerutti S; Orlandini G
    Kidney Int; 1996 Aug; 50(2):609-17. PubMed ID: 8840293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple model of intra-extracellular potassium kinetics and removal applied to constant and potassium-profiled dialysis.
    Bolasco P; Concas G; Steckiph D; Grandi F; Polacchini M
    J Nephrol; 2008; 21(3):384-93. PubMed ID: 18587727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of profile haemodialysis on intra-/extracellular fluid shifts and the release of vasoactive hormones in elderly patients on regular dialysis treatment.
    Ebel H; Laage C; Keuchel M; Dittmar A; Saure B; Ehlenz K; Lange H
    Nephron; 1997; 75(3):264-71. PubMed ID: 9069446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potassium metabolism in patients with chronic kidney disease. Part II: patients on dialysis (stage 5).
    Musso CG
    Int Urol Nephrol; 2004; 36(3):469-72. PubMed ID: 15783126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium balance and acid-base changes in patients undergoing regular haemodialysis therapy.
    Morgan AG; Burkinshaw L; Robinson PJ; Rosen SM
    Br Med J; 1970 Mar; 1(5699):779-83. PubMed ID: 5443380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysate composition and intradialytic metabolic, acid-base and potassium changes.
    Ward RA; Wathen RL; Williams TE; Harding GB
    Kidney Int; 1987 Jul; 32(1):129-35. PubMed ID: 3306095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factors which influence phosphorus removal in hemodialysis].
    Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
    Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal composition of the dialysate, with emphasis on its influence on blood pressure.
    Locatelli F; Covic A; Chazot C; Leunissen K; Luño J; Yaqoob M
    Nephrol Dial Transplant; 2004 Apr; 19(4):785-96. PubMed ID: 15031331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model-based analysis of potassium removal during hemodialysis.
    Ciandrini A; Severi S; Cavalcanti S; Fontanazzi F; Grandi F; Buemi M; Mura C; Bajardi P; Badiali F; Santoro A
    Artif Organs; 2009 Oct; 33(10):835-43. PubMed ID: 19681843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluid dynamics during hemodialysis in relationship to sodium gradient between dialysate and plasma.
    Sarkar SR; Wystrychowski G; Zhu F; Usvyat LA; Kotanko P; Levin NW
    ASAIO J; 2007; 53(3):339-42. PubMed ID: 17515726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluid distribution abnormalities and influence of hemodialysis on fluid distribution in patients on maintenance hemodialysis].
    Zuo L; Wang M; Wei H; Feng LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):467-70. PubMed ID: 16224514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of sodium in hemodialysis.
    Flanigan MJ
    Kidney Int Suppl; 2000 Aug; 76():S72-8. PubMed ID: 10936802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialysate Potassium, Dialysate Magnesium, and Hemodialysis Risk.
    Pun PH; Middleton JP
    J Am Soc Nephrol; 2017 Dec; 28(12):3441-3451. PubMed ID: 28993507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differences of asymmetric dimethylarginine removal by different dialysis treatments.
    Zhang DL; Liu J; Liu S; Zhang Y; Liu WH
    Ren Fail; 2010; 32(8):935-40. PubMed ID: 20722560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of albuterol treatment on subsequent dialytic potassium removal.
    Allon M; Shanklin N
    Am J Kidney Dis; 1995 Oct; 26(4):607-13. PubMed ID: 7573015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of low-potassium dialysate.
    Hou S; McElroy PA; Nootens J; Beach M
    Am J Kidney Dis; 1989 Feb; 13(2):137-43. PubMed ID: 2916568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma potassium in patients with terminal renal failure during and after haemodialysis; relationship with dialytic potassium removal and total body potassium.
    Blumberg A; Roser HW; Zehnder C; Müller-Brand J
    Nephrol Dial Transplant; 1997 Aug; 12(8):1629-34. PubMed ID: 9269640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.